Subacute thyroiditis in a patient with MS treated with interferon beta-1a.
Kreiss
Y
Y
Department of Medicine C, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel.
Cohen
O
O
Pras
E
E
Achiron
A
A
D000208:Acute Disease; D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000009:adverse effects*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009288:Naproxen / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D013966:Thyroiditis / Q000139:chemically induced* / Q000188:drug therapy
D000276:Adjuvants, Immunologic; D000894:Anti-Inflammatory Agents, Non-Steroidal; D009288:Naproxen; D016899:Interferon-beta; D011433:Propranolol; D000068556:Interferon beta-1a